This productive discussion with FDA reviewers gives Ernest leadership renewed confidence our development plan is on the ...
Market valued at $27.64B in 2024, projected 3.94% CAGR growth driven by petroleum refining, green chemistry, biocatalysts, and environmental catalyst demand.